No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.

@article{Spurdle2001NoSA,
  title={No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.},
  author={Amanda B Spurdle and Penelope M Webb and David M. Purdie and Xiao-qing Chen and A Richard Green and Georgia Chenevix-Trench},
  journal={Carcinogenesis},
  year={2001},
  volume={22 5},
  pages={717-21}
}
Epidemiological studies suggest that ovarian cancer is an endocrine-related tumour, and progesterone exposure specifically may decrease the risk of ovarian cancer. To assess whether the progesterone receptor (PR) exon 4 valine to leucine amino acid variant is associated with specific tumour characteristics or with overall risk of ovarian cancer, we examined 551 cases of epithelial ovarian cancer and 298 unaffected controls for the underlying G-->T nucleotide substitution polymorphism… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2006
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 16 references

heterozygosity and KRAS 2 mutations in ovarian neoplasms : Environmental and heritable factors in the causation of cancer . NEJM , clinicopathological correlations

E. Pukkala, A. Skytthe, K. Hemminki
Genes Chr . Cancer • 2000

Analysis of loss of Koskenvuo,M., Pukkala,E., Skytthe,A

P. Lichtenstein, N. V. Holm, +5 authors T Hurst
1997

Functional analysis of mutated progesterone receptor that cosegregates with sporadic ovarian cancer

L. A. Jones, D. G. Kieback
1997

genetics and clinical implications

J. M. Lancaster, A. Berchuck, M. E. Carney, R. Wiseman, J. A. Taylor
Gynecol . Oncol . • 1997

Loss promotor polymorphism and ovarian cancer risk

L. Taylor, J. Mackay, C. M. Steel, R. C. Leonard, J. F. Smyth
Clin . Cancer Res . • 1995

ovarian cancer [letter; comment

P. Russell, B. Susil
Br. J. Cancer, • 1995

Similar Papers

Loading similar papers…